A

Amneal Pharmaceuticals

AMRX

7.17000
USD
-0.165
(-2.25%)
Market Closed
Volume
50,161
EPS
0
Div Yield
0
P/E
142
Market Cap
2,621,168,167
Related Instruments
ABBV
4.380
(2.36%)
189.700 USD
GSK
0.865
(2.23%)
39.650 USD
JNJ
2.930
(1.86%)
160.770 USD
MRK
0.680
(0.60%)
113.800 USD
NVS
0.650
(0.58%)
112.100 USD
PFE
0.115
(0.38%)
30.650 USD
T
TEVA
0.100
(0.57%)
17.530 USD
News

Title: Amneal Pharmaceuticals

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Amneal Pharmaceuticals Inc is a global pharmaceutical company operating primarily in the U.S., India, and Ireland. With three reportable segments; Generics, Specialty, and AvKARE - It develop, manufacture, and distribute a diverse portfolio of essential medicines. The Generics segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targetingthe central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.